{"altmetric_id":4147572,"counts":{"readers":{"mendeley":14,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:34807118"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4f63cf058f610002f6e","doi":"10.1016\/j.jns.2008.07.021","first_seen_on":"2015-06-13T18:21:34+00:00","issns":["0022-510X"],"journal":"Journal of the Neurological Sciences","last_mentioned_on":1341483867,"links":["http:\/\/dx.doi.org\/10.1016\/j.jns.2008.07.021"],"pdf_url":"http:\/\/www.jns-journal.com\/article\/S0022510X08003699\/pdf","pmid":"18722628","publisher":"Elsevier","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Neurosciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Neuroscience"],"subjects":["neurology"],"title":"Facial onset sensory and motor neuronopathy (FOSMN) syndrome responding to immunotherapies","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/facial-onset-sensory-motor-neuronopathy-fosmn-syndrome-responding-immunotherapies"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3999641,"mean":5.0355594219728,"rank":918769,"this_scored_higher_than_pct":63,"this_scored_higher_than":2531194,"rank_type":"exact","sample_size":3999641,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":110829,"mean":6.8659270256125,"rank":30848,"this_scored_higher_than_pct":69,"this_scored_higher_than":77218,"rank_type":"exact","sample_size":110829,"percentile":69},"this_journal":{"total_number_of_other_articles":1092,"mean":2.4349679193401,"rank":174,"this_scored_higher_than_pct":73,"this_scored_higher_than":799,"rank_type":"exact","sample_size":1092,"percentile":73},"similar_age_this_journal_3m":{"total_number_of_other_articles":114,"mean":2.4190973451327,"rank":20,"this_scored_higher_than_pct":80,"this_scored_higher_than":92,"rank_type":"exact","sample_size":114,"percentile":80}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":2,"Researcher":4,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":1,"Other":1,"Student  > Master":2,"Student  > Bachelor":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":9,"Neuroscience":1,"Sports and Recreations":1,"Agricultural and Biological Sciences":2,"Nursing and Health Professions":1}}},"geo":{"mendeley":{"AR":1,"BR":1}}},"posts":{"wikipedia":[{"title":"Facial Onset Sensory Motor Neuropathy syndrome","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=500778644#altmetric_citation_1","license":"public","citation_ids":[4147572],"posted_on":"2012-07-05T10:24:27+00:00","summary":"Facial Onset Sensory and Motor Neuropathy syndrome (FOSMN) is an extremely rare disease characterised by sensory and motor loss beginning in the face and spreading to involve an increasingly larger area including the upper arms.","page_url":"http:\/\/en.wikipedia.org\/?curid=34807118","wiki_lang":"en","author":{"name":"Rjwilmsi","url":"http:\/\/en.wikipedia.org\/wiki\/User:Rjwilmsi"}}]}}